Drug Profile
Hepatitis B edible vaccine - ProdiGene
Latest Information Update: 22 Apr 2003
Price :
$50
*
At a glance
- Originator ProdiGene
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 03 Apr 2000 New profile
- 03 Apr 2000 Preclinical development for Hepatitis B in USA (PO)